New York City-based NYU Langone has expanded cardiology services at the NYU Langone Hospital—Brooklyn. Previously, NYU Langone patients living in Brooklyn were travelling to Manhattan to receive advanced cardiac care. 

Salt Lake City-based Intermountain Health's St. Mary's Regional Hospital in Grand Junction, Colo., recently became the first community hospital in the nation to receive vascular verification from the American College of Surgeons and the Society for Vascular Surgery.

Women in academic cardiothoracic surgery earn 80% to 87% of the salary men with equal academic rank earn, according to a study published Dec. 2 in The Annals of Thoracic Surgery. 

After CMS released its finalized 2025 physician fee schedule, which will reduce reimbursements by 2.83%, some cardiologists are raising concerns over what they call an unstable healthcare system, according to a Dec. 9 TCTMD report. 

Experts agree more care should be given to cardiovascular safety concerns during clinical cancer trials. The Cardiovascular Safety Research Consortium published new recommendations for addressing those concerns Dec. 10 in JACC: CardioOncology. 

The American College of Cardiology has developed an Expert Consensus Decision Pathway for the diagnosis and management of adult patients with acute myocarditis. The pathway was published Dec. 10 in the Journal of the American College of Cardiology. 

Charleston, W.Va.-based Vandalia Health’s Mon Health Heart & Vascular Center has launched a new telecardiology service in partnership with the system's Webster Springs, W.Va.-based Webster Memorial Hospital.

Auburn (N.Y.) Community Hospital broke ground on an expansion to its heart institute while launching a $50 million fundraising campaign to support additional improvement projects, according to a Dec. 6 report from The Citizen. 

A team at Austin, Texas-based St. David's Medical Center became the first team in the U.S. to use a newly FDA-approved novel pulsed field ablation system to treat patients with atrial fibrillation.

A team at HonorHealth Scottsdale (Ariz.) Shea Medical Center performed the state's first tricuspid valve replacement using the Edwards Lifesciences' Evoque system outside of a clinical trial.

Cardiologists from Pediatrix Cardiology Associates and the Tampa Bay Adult Congenital Heart Center have joined Clearwater, Fla.-based BayCare Health System's physician practice, BayCare Medical Group.

Using an AI-powered electrocardiogram to diagnose low ejection fraction produced a cost-effectiveness ratio of $27,858 per quality-adjusted life year, according to a study published Oct. 25 in Mayo Clinic Proceedings: Digital Health.

A team at Morgantown, W. Va.-based WVU Medicine's WVU Heart and Vascular Institute performed the world's first combined robotic aortic valve replacement and coronary artery bypass operation.

Through funding from Bristol Myers Squibbs, the American Heart Association has launched a three-year initiative to improve and standardize care for patients with hypertrophic cardiomyopathy. 

Baylor Scott & White The Heart Hospital-Plano in Texas cut times of cardiogenic shock diagnosis in half after implementing a quality improvement project that included nurse education and an electronic shock team alert, according to a study published Dec. 1 in Critical Care Nurse. 

Winchester, Va.-based Valley Health has renamed its heart and vascular center in recognition of a "significant contribution" made to the system.

Madison, Wis.-based UW Health Kids and Milwaukee-based Children's Wisconsin are forming a joint venture to expand access to pediatric cardiac care. 

From $700 million cardiovascular care initiatives to international AI applications, here are 10 recently announced cardiology partnerships:

The CDC and CMS added four NYC Health + Hospitals' facilities to the Million Hearts Hypertension Control Champion list in 2024, which recognizes hospitals who have achieved blood pressure control for at least 80% of adult hypertension patients. 

With deaths from obesity-related heart disease reportedly increasing by 180% over the past 20 years, more research is being done to learn how GLP-1 medications such as Ozempic, Wegovy, Mounjaro and Zepbound can address outcomes in cardiovascular health.